Short-term tolerability and dose toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors (NET)

被引：0
|
作者：
Plaza, Bonilla J. [1 ]
Lorca, Martinez A. [1 ]
Martinez, Navarro T. [1 ]
Hernandez, Azpeitia P. [1 ]
Alonso-Gordoa, T. [1 ]
Molina-Cerrillo, J. [1 ]
Diez, Orduna M. D. P. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
prrt; 177lu; toxicity;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H04
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [2] 177Lu-Dotatate for Midgut Neuroendocrine Tumors REPLY
    Strosberg, Jonathan
    Krenning, Eric
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1392
  • [3] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [4] Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE
    Casanovas, M. Mitjavila
    Percovich, J.
    Bello, P.
    Arbizu, J.
    Pubul, V.
    Riesco, M.
    Muros, M.
    Gonzalez, E.
    Carmona-Bayonas, A.
    Estenoz, J.
    Rotger, A.
    Llana, B.
    Aller, J.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S593 - S594
  • [5] Therapeutic response evaluation in patients with neuroendocrine tumors treated with 177Lu-DOTATATE
    Gupta, Santosh
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Dosimetric studies of 177Lu-DOTATATE administered into neuroendocrine tumors
    Gupta, Santosh
    Singla, Suhas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Bal, C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [7] Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
    Sansovini, Maddalena
    Severi, Stefano
    Ambrosetti, Alice
    Monti, Manuela
    Nanni, Oriana
    Sarnelli, Anna
    Bodei, Lisa
    Garaboldi, Lucia
    Bartolomei, Mirco
    Paganelli, Giovanni
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 347 - 354
  • [8] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [9] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Abou Jokh Casas, Estephany
    Pubul Nunez, Virginia
    Anido-Herranz, Urbano
    Mallon Araujo, Maria del Carmen
    Pombo Pasin, Maria del Carmen
    Pumar, Miguel Garrido
    Cabezas Agricola, Jose Manuel
    Manuel Cameselle-Teijeiro, Jose
    Hilal, Ashraf
    Ruibal Morell, Alvaro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (13) : 1513 - 1524
  • [10] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Estephany Abou Jokh Casas
    Virginia Pubul Nú?ez
    Urbano Anido-Herranz
    María del Carmen Mallón Araujo
    Maria del Carmen Pombo Pasín
    Miguel Garrido Pumar
    José Manuel Cabezas Agrícola
    José Manuel Cameselle-Teijeiro
    Ashraf Hilal
    álvaro Ruibal Morell
    World Journal of Gastroenterology, 2020, 26 (13) : 1513 - 1524
12345